| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
72,540,000 |
| Market
Cap: |
348.92(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$4.14 - $7.08 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile KemPharm is a specialty pharmaceutical company focused on the discovery and development of treatments for central nervous system (CNS) and rare disease indications that allow it to target areas with unmet needs. Co.'s prodrug product candidate pipeline is focused on the idiopathic hypersomnia (IH) and other CNS/rare diseases. Co.'s approved product, AZSTARYS®, a once-daily treatment for attention deficit hyperactivity disorder in patients, age six years and older, contains its prodrug, serdexmethylphenidate (SDX). Co.'s primary clinical development product candidate, KP1077, is based on SDX, its prodrug of d-methlyphenidate and is in development for the treatment of IH and narcolepsy.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
36,240 |
103,219 |
| Total Buy Value |
$0 |
$0 |
$182,489 |
$489,462 |
| Total People Bought |
0 |
0 |
5 |
11 |
| Total Buy Transactions |
0 |
0 |
10 |
26 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-02-04 |
2023-11-03 |
2023-05-05 |
2022-05-05 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Mickle Christal M M |
VP Operations & Prod Dev |
• – • |
2015-10-28 |
4 |
OE |
$5.85 |
$25,249 |
D/D |
4,316 |
100,604 |
|
- |
|
| Mickle Travis C |
President & CEO |
• • • |
2015-10-28 |
4 |
OE |
$5.85 |
$25,249 |
D/D |
4,316 |
100,604 |
|
- |
|
| Mickle Christal M M |
VP Operations & Prod Dev |
• – • |
2015-10-02 |
4 |
GA |
$0.00 |
$0 |
I/I |
401,077 |
157,197 |
|
- |
|
| Mickle Christal M M |
VP Operations & Prod Dev |
• – • |
2015-10-02 |
4 |
GD |
$0.00 |
$0 |
I/I |
157,197 |
1,381,176 |
|
- |
|
| Mickle Christal M M |
VP Operations & Prod Dev |
• – • |
2015-10-02 |
4 |
GD |
$0.00 |
$0 |
D/D |
243,880 |
33,214 |
|
- |
|
| Mickle Travis C |
President & CEO |
• • • |
2015-10-02 |
4 |
GA |
$0.00 |
$0 |
I/I |
401,077 |
243,880 |
|
- |
|
| Mickle Travis C |
President & CEO |
• • • |
2015-10-02 |
4 |
GD |
$0.00 |
$0 |
I/I |
243,880 |
33,214 |
|
- |
|
| Mickle Travis C |
President & CEO |
• • • |
2015-10-02 |
4 |
GD |
$0.00 |
$0 |
D/D |
157,197 |
1,381,176 |
|
- |
|
| Tierney David S |
Director |
– • – |
2015-04-21 |
4 |
B |
$11.00 |
$55,000 |
D/D |
5,000 |
5,000 |
2.39 |
- |
|
| Johnson Gordon K |
COO & CFO |
• – – |
2015-04-21 |
4 |
B |
$11.00 |
$22,000 |
D/D |
2,000 |
2,000 |
2.74 |
- |
|
| Thompson Danny L |
Director |
– • – |
2015-04-21 |
4 |
A |
$0.00 |
$0 |
I/I |
91,687 |
91,687 |
|
- |
|
| Thompson Danny L |
Director |
– • – |
2015-04-21 |
4 |
A |
$0.00 |
$0 |
D/D |
7,373 |
7,373 |
|
- |
|
| Saluri Joseph |
Director |
– • – |
2015-04-21 |
4 |
A |
$0.00 |
$0 |
D/D |
4,555 |
4,555 |
|
- |
|
| Mickle Christal M M |
VP Operations & Prod Dev |
• – • |
2015-04-21 |
4 |
A |
$0.00 |
$0 |
D/D |
102,271 |
96,288 |
|
- |
|
| Mickle Travis C |
President & CEO |
• • • |
2015-04-21 |
4 |
A |
$0.00 |
$0 |
D/D |
96,288 |
96,288 |
|
- |
|
| Mickle Travis C |
President & CEO |
• • • |
2015-04-21 |
4 |
A |
$0.00 |
$0 |
I/I |
5,983 |
277,094 |
|
- |
|
| Plooster Matthew R |
Director |
– • – |
2015-04-21 |
4 |
A |
$0.00 |
$0 |
I/I |
429,421 |
428,304 |
|
- |
|
| Plooster Matthew R |
Director |
– • – |
2015-04-21 |
4 |
A |
$0.00 |
$0 |
D/D |
4,545 |
4,545 |
|
- |
|
| Guenther Sven |
Exec VP R&D |
• – – |
2015-04-21 |
4 |
A |
$0.00 |
$0 |
D/D |
23,852 |
43,852 |
|
- |
|
| Guenther Sven |
Exec VP R&DOfficer |
• – – |
2015-04-15 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
20,000 |
|
- |
|
| Mickle Christal M M |
VP Operations & Prod DevOffice |
• – • |
2015-04-15 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
1,999,997 |
|
- |
|
| Mickle Christal M M |
VP Operations & Prod DevOffice |
• – • |
2015-04-15 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
271,111 |
|
- |
|
| Mickle Travis C |
President & CEOOfficer |
• • • |
2015-04-15 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
732,735 |
|
- |
|
| Mickle Travis C |
President & CEOOfficer |
• • • |
2015-04-15 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
1,538,373 |
|
- |
|
149 Records found
|
|
Page 6 of 6 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
0.06 (1.26%) 
